Suchergebnisse - "Okada, Annabelle A"

PubPharm (306)

31

Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo

enthalten in: Graefe's archive for clinical and experimental ophthalmology | 2022

von Nagahori, K. | Keino, H. | Nakayama, M. | +5

32

Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo

enthalten in: Graefe's archive for clinical and experimental ophthalmology | 2022

von Nagahori, K. | Keino, H. | Nakayama, M. | +5

33

Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study

enthalten in: Japanese journal of ophthalmology | 2022

von Tanaka, K. | Koizumi, H. | Tamashiro, T. | +21

34

Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study

enthalten in: Japanese journal of ophthalmology | 2022

von Tanaka, K. | Koizumi, H. | Tamashiro, T. | +21

35

Short-term results for brolucizumab in treatment-naïve neovascular age-related macular degeneration: a Japanese multicenter study

enthalten in: Japanese journal of ophthalmology | 2022

von Tanaka, K. | Koizumi, H. | Tamashiro, T. | +21

36

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup

enthalten in: Advances in therapy | 2022

von Okada, A. | Takahashi, K. | Ohji, M. | +3

37

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup

enthalten in: Advances in therapy | 2022

von Okada, A. | Takahashi, K. | Ohji, M. | +3

38

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in the ALTAIR Study: 96-Week Outcomes in the Polypoidal Choroidal Vasculopathy Subgroup

enthalten in: Advances in therapy | 2022

von Okada, A. | Takahashi, K. | Ohji, M. | +3

39

Correction to: Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study

enthalten in: Graefe's archive for clinical and experimental ophthalmology | 2022

von Ohji, M. | Okada, A. | Sasaki, K. | +3

40

Correction to: Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study

enthalten in: Graefe's archive for clinical and experimental ophthalmology | 2022

von Ohji, M. | Okada, A. | Sasaki, K. | +3